Overview
- 32 inspections across 32 sites are on record.
- 73 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-20.
At a glance
Inspections
32
Sites
32
Observations
73
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bausch & Lomb Incorporated | 20 Mar 2026 | Human Drugs | On file |
| Catalent Pharma Solutions, LLC | 30 Jan 2026 | Human Drugs | On file |
| KRS PHARMACEUTICALS PRIVATE LIMITED | 21 Nov 2025 | Human Drugs | On file |
| Dr. Reddy's Laboratories Limited | 14 Nov 2025 | Human Drugs | |
| Matrix Pharmacorp Private Limited | 7 Nov 2025 | Human Drugs | On file |
Sites inspected
Bausch & Lomb IncorporatedTampa, United States1 insp.
Catalent Pharma Solutions, LLCSaint Petersburg, United States1 insp.
KRS PHARMACEUTICALS PRIVATE LIMITEDAnakapalli, India1 insp.
Dr. Reddy's Laboratories LimitedRansthalam Mandal, Srikakulam District, India1 insp.
Matrix Pharmacorp Private LimitedVisakhapatnam, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Dorothy P Kramer5 shared
Nicole E Knowlton4 shared
Jose E Melendez4 shared
Suzanne N Vallez3 shared
Javier O Vega3 shared
Angelica M Hernandez2 shared
Marian E Ramirez2 shared
Mabany Lizardi2 shared
Mickell Smith1 shared
Tammy T Brown1 shared
Full investigator report
Get the verbatim findings behind Damaris Y Hernandez's 73 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site